FR2074627A1 - Ppsoriasis treatment compsn - Google Patents

Ppsoriasis treatment compsn

Info

Publication number
FR2074627A1
FR2074627A1 FR7000991A FR7000991A FR2074627A1 FR 2074627 A1 FR2074627 A1 FR 2074627A1 FR 7000991 A FR7000991 A FR 7000991A FR 7000991 A FR7000991 A FR 7000991A FR 2074627 A1 FR2074627 A1 FR 2074627A1
Authority
FR
France
Prior art keywords
pref
treatment
composn
effects
ppsoriasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7000991A
Other languages
English (en)
French (fr)
Other versions
FR2074627B1 (ja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SOCRES
Original Assignee
SOCRES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SOCRES filed Critical SOCRES
Priority to FR7000991A priority Critical patent/FR2074627A1/fr
Priority to DE19712101393 priority patent/DE2101393A1/de
Publication of FR2074627A1 publication Critical patent/FR2074627A1/fr
Application granted granted Critical
Publication of FR2074627B1 publication Critical patent/FR2074627B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01035—Hyaluronoglucosaminidase (3.2.1.35), i.e. hyaluronidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7000991A 1970-01-13 1970-01-13 Ppsoriasis treatment compsn Granted FR2074627A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR7000991A FR2074627A1 (en) 1970-01-13 1970-01-13 Ppsoriasis treatment compsn
DE19712101393 DE2101393A1 (de) 1970-01-13 1971-01-13 Medikament zur Behandlung von Psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7000991A FR2074627A1 (en) 1970-01-13 1970-01-13 Ppsoriasis treatment compsn

Publications (2)

Publication Number Publication Date
FR2074627A1 true FR2074627A1 (en) 1971-10-08
FR2074627B1 FR2074627B1 (ja) 1973-01-12

Family

ID=9048920

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7000991A Granted FR2074627A1 (en) 1970-01-13 1970-01-13 Ppsoriasis treatment compsn

Country Status (2)

Country Link
DE (1) DE2101393A1 (ja)
FR (1) FR2074627A1 (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998036733A2 (en) * 1997-02-24 1998-08-27 Michael Albert Kamm Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
EP1085859A1 (en) * 1998-06-11 2001-03-28 University Of Medicine And Dentistry Of New Jersey Wound treatment through inhibition of adenosine diphosphate ribosyl transferase
US8048875B1 (en) 1997-02-24 2011-11-01 S.L.A. Pharma Ag Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998036733A2 (en) * 1997-02-24 1998-08-27 Michael Albert Kamm Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
WO1998036733A3 (en) * 1997-02-24 1998-11-26 Michael Albert Kamm Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
US8048875B1 (en) 1997-02-24 2011-11-01 S.L.A. Pharma Ag Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
US8318721B2 (en) 1997-02-24 2012-11-27 S.L.A. Pharma Ag Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
US8906903B2 (en) 1997-02-24 2014-12-09 S.L.A. Pharma Ag Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
EP1085859A1 (en) * 1998-06-11 2001-03-28 University Of Medicine And Dentistry Of New Jersey Wound treatment through inhibition of adenosine diphosphate ribosyl transferase
EP1085859A4 (en) * 1998-06-11 2003-02-26 Univ New Jersey Med TREATMENT OF INJURY BY INHIBITION OF ADENOSINE DIPHOSPHATE-RIBOSYL TRANSFERASE

Also Published As

Publication number Publication date
DE2101393A1 (de) 1971-09-02
FR2074627B1 (ja) 1973-01-12

Similar Documents

Publication Publication Date Title
CA947279A (en) METHOD OF PRODUCING .alpha.-DIPEPTIDE ESTERS OF L-ASPARTIC ACID
AU4149672A (en) Mononitrte esters of 1,4:3, 6-dianhydro-d-glucitol
FR2074627A1 (en) Ppsoriasis treatment compsn
CA976365A (en) Methods of producing superconductors
CA1010881A (fr) Procede de preparation de nouveaux derives de l'acide butyrique
CA969885A (en) Simultaneous production of aromatic hydrocarbons and isobutane
CA989873A (en) Catalytic production of 1,1-difluoroethane
CA936653A (en) Treatment of titanium dioxide
CA987314A (en) Derivatives of 9-oxo-13-trans-prostenoic acid esters
AU468132B2 (en) Process forthe preparation of chloroformic acid esters and cyclic carbonates
CA990670A (en) Enzymatic production of 6-aminopenicillanic acid
CA864531A (en) Enzymic treatment of natural products
CA978691A (en) Polyimides and methods of producing same
CA1026620A (en) Sulfinate esters as flavoring agents
CA868943A (en) PRODUCTION OF .alpha.-CHLOROPROPIONIC ACID
CA866180A (en) Method of producing anti-adrenal activity and compositions therefor
CA873880A (en) 2-alcoxy-4,5-azimido benzamides and their method of manufacture
CA880793A (en) Manufacture of titanium dioxide
AU443748B2 (en) Process forthe manufacture of optically active bicycloalkane derivatives
CA879726A (en) Production of o-benzoylbenzoic acid
CA877981A (en) Production of o-benzoylbenzoic acid
CA605951A (en) Method of creping tissue and product thereof
AU241318B2 (en) Process forthe manufacture of titanium dioxide
AU423068B2 (en) Prophylaxis and treatment of cardiac disorders
CA860920A (en) Racemization of optically active transcyclopropanecarboxylic acids and their derivatives